Showing 4,901 - 4,920 results of 49,000 for search '(( a ((step decrease) OR (mean decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.91s Refine Results
  1. 4901
  2. 4902
  3. 4903
  4. 4904
  5. 4905
  6. 4906
  7. 4907
  8. 4908
  9. 4909
  10. 4910

    Ovariectomy (OVX) induced decrease in hexokinase expression and activity: prevention by 17β-estradiol. by Fan Ding (302565)

    Published 2013
    “…<p>A. In female 3×TgAD brains, OVX induced a significant decrease in protein expression of hexokinase 2 (*, P<0.05, bars represent mean value±SEM, n = 5−6), which was partially prevented by E2 treatment. …”
  11. 4911

    Image5_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  12. 4912

    Image2_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  13. 4913

    Image4_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  14. 4914

    Image7_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  15. 4915

    Image6_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  16. 4916

    Image1_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  17. 4917

    Image3_PKA inhibition is a central step in D,L-methadone-induced ER Ca2+ release and subsequent apoptosis in acute lymphoblastic leukemia.JPEG by Hamza Kamran (18433152)

    Published 2024
    “…The 14–22 amide (myr) PKA inhibitor alone elicits ER Ca<sup>2+</sup> release, and subsequent treatment with D,L-methadone does not cause additional ER Ca<sup>2+</sup> release, indicating that PKA inhibition is a key step in D,L-methadone-induced ER Ca<sup>2+</sup> release and can bypass the D,L-methadone-OPRM1-AC-cAMP step. …”
  18. 4918

    AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased. by Margaret Coates (6058580)

    Published 2019
    “…Genes highlighted in blue are downregulated genes of interest; genes highlighted in red are upregulated genes of interest. While <i>DCD</i> is downregulated in HS lesional skin, many other AMPs and interferon-associated molecules are enriched in lesional HS. …”
  19. 4919
  20. 4920